NVST vs TNGX
Envista Holdings vs Tango Therapeutics, Inc. — AI-powered side-by-side comparison
NVST
Envista Holdings
76
Strong Buy
VS
TNGX
Tango Therapeutics, Inc.
55
Buy
| Metric | NVST | TNGX |
|---|
| AI Score |
76
|
55
|
| Price |
$28.51
|
$26.32
|
| P/E Ratio |
48.34×
|
-30.99×
|
| ROE |
1.5%
|
-29.3%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
55.5%
|
98.2%
|
| Debt / Equity |
0.52×
|
0.03×
|
| Dividend Yield |
0.0%
|
0.0%
|
| RSI (14) |
59.3
|
38.9
|
| Beta |
0.861
|
1.127
|
| Expected Upside |
+1.4%
|
—
|
AI Committee View
Current Innellis committee reasoning for NVST versus TNGX.
NVST leads by 21 points.
NVST scores 76/100 (Strong Buy) versus TNGX at 55/100 (Buy).
NVST Committee View
100% agreement
4 analysts
The primary driver is 5 consecutive earnings beats -- consistent execution. The main limiting factor is 2 existing position pair(s) are highly correlated already. The committee is constructive but not yet at full conviction.
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
Bear Case
- Weekly trend is bearish while daily is bullish — against the higher-timeframe trend.
- Risk/reward is unfavorable: 14.2% downside vs 1.4% upside.
TNGX Committee View
50% agreement
4 analysts
The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Risk Analyst remains cautious — bollinger bandwidth of 16.2% signals elevated volatility. This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- VIX regime is low -- calm backdrop supports risk-taking — Macro
- Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
- MACD histogram negative -- bearish momentum — Technical
- Bollinger bandwidth of 16.2% signals elevated volatility — Risk
- No news coverage in the last 14 days -- limited independent confirmation either way — News